Intravascular substance P dilates cerebral parenchymal vessels through a specific tachykinin NK1 receptor in cats. [electronic resource]

By:

Kobari, M

Contributor(s):

Tomita, M
Tanahashi, N
Yokoyama, M
Takao, M
Fukuuchi, Y

Producer: 19970403Description: 269-74 p. digitalISSN:

0014-2999

Subject(s):

Animals
Blood Pressure -- drug effects
Blood Volume -- drug effects
Carotid Arteries
Cats
Cerebrovascular Circulation -- drug effects
Dipeptides -- pharmacology
Dose-Response Relationship, Drug
Indoles -- pharmacology
Injections, Intra-Arterial
Microcirculation -- drug effects
Receptors, Neurokinin-1 -- drug effects
Substance P -- administration & dosage
Vasodilator Agents -- administration & dosage

Online resources:

Available from publisher's website

In: European journal of pharmacology vol. 317

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Browse results Close

Back to results

1 The current status of apo E4 as a risk factor for Alzheimer's disease: an epidemiological perspective.
by Ritchie, K
2 Comparison between the enzymatic vitros assay for creatinine determination and three other methods adapted on the Olympus analyzer.
by Badiou, S
3 DNA restriction polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster: a genetic determinant of atherosclerosis in type 2 (non-insulin-dependent) diabetes mellitus.
by Renard, E
4 Adaptation and evaluation of the Randox full-range CRP assay on the Olympus AU2700.
by Dupuy, A M
5 Determination of beta2-microglobulin in biological samples using an immunoenzymometric assay (chemiluminescence detection) or an immunoturbidimetric assay: comparison with a radioimmunoassay.
by Terrier, N
6 Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
by Dupuy, A M
7 Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
by Badiou, S
8 Immunonephelometric determination of fibrinogen on citrated or heparinized plasma: comparison with functional Clauss method.
by Bargnoux, A S
9 [Carbonyl stress and oxidatively modified proteins in chronic renal failure].
by Bargnoux, A-S
10 Renal transplantation decreases osteoprotegerin levels.
by Bargnoux, A S
11 Evaluation of a capillary zone electrophoresis system versus a conventional agarose gel system for routine serum protein separation and monoclonal component typing.
by Roudiere, L
12 Discrepancies between apolipoprotein E phenotyping and genotyping in the elderly.
by Dupuy, A M
13 [Is C-reactive protein a marker of inflammation?].
by Dupuy, A M
14 Preliminary evaluation of a new chemiluminescence assay (Liaison Cyclosporine; DiaSorin Laboratories) allowing both C0 and C2 cyclosporine levels determination: comparison with RIA method.
by Olejnik, Y
15 Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir-containing regimen: an index of atherogenicity?
by Badiou, S
16 The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease.
by Dupuy, A M
17 The V-twin system (Dade Behring Laboratories): a useful tool for immunosuppressive drug monitoring.
by Elaerts, S
18 Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
by Straczek, C
19 Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia.
by Tur, M D
20 Effects of a supplementation during exercise and recovery.
by Thomas, C

Intravascular substance P dilates cerebral parenchymal vessels through a specific tachykinin NK1 receptor in cats.

APA

Kobari M., Tomita M., Tanahashi N., Yokoyama M., Takao M. & Fukuuchi Y. (19970403). Intravascular substance P dilates cerebral parenchymal vessels through a specific tachykinin NK1 receptor in cats. : European journal of pharmacology.

Chicago

Kobari M, Tomita M, Tanahashi N, Yokoyama M, Takao M and Fukuuchi Y. 19970403. Intravascular substance P dilates cerebral parenchymal vessels through a specific tachykinin NK1 receptor in cats. : European journal of pharmacology.

Harvard

Kobari M., Tomita M., Tanahashi N., Yokoyama M., Takao M. and Fukuuchi Y. (19970403). Intravascular substance P dilates cerebral parenchymal vessels through a specific tachykinin NK1 receptor in cats. : European journal of pharmacology.

MLA

Kobari M, Tomita M, Tanahashi N, Yokoyama M, Takao M and Fukuuchi Y. Intravascular substance P dilates cerebral parenchymal vessels through a specific tachykinin NK1 receptor in cats. : European journal of pharmacology. 19970403.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC